NaderNajafianMD

Nephrology • Boston, MA

Assistant Professor of Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Najafian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Najafian's full profile

Already have an account?

Office
Brigham and Womans Hospital Immunogenetics Transplant
75 Francis St PBB Adm 1
Boston, MA 02115
Phone+1 617-732-5868

Education & Training

Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1998 - 2002
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
University of Vienna Faculty of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 1997 - 2026
CA State Medical License 1997 - 2025
FL State Medical License 2013 - 2025
IA State Medical License 1995 - 2002
American Board of Internal Medicine Nephrology

Clinical Trials

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab Start of enrollment: 2008 Sep 01
Completed
A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome Start of enrollment: 2017 Sep 19
Withdrawn
Phase 2
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP) Start of enrollment: 2018 Apr 26
Completed
Phase 1
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) Start of enrollment: 2019 Sep 30
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

4 citations
Advancing mouse models for transplantation research.
Paolo Cravedi, Leonardo V Riella, Mandy L Ford, Anna Valujskikh, Madhav C Menon
American Journal of Transplantation. 2024-08-01
18 citations
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Carla Nester, Gerald B Appel, Andrew S Bomback, Koenraad Peter Bouman, H Terence Cook
American Journal of Nephrology. 2022-01-01
19 citations
Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
Ciara N. Magee, Naoka Murakami, Thiago J. Borges, Tetsunosuke Shimizu, Kassem Safa
Circulation. 2019-09-03